Changes to our trading names and address – MSD and Organon & Co. read more
Changes to our trading names and address
Please note that in 2021, MSD will be spinning off products from its women’s health, legacy brands, and biosimilars franchises into a new independent, publicly traded company known as Organon & Co.
Due to legal entity separation in advance of this spin off, we now have two UK registered businesses, MSD and Organon. Organon & Co. is a wholly owned subsidiary of Merck & Co., Inc. of Kenilworth, New Jersey, USA.
As a result of the future spin-off of Organon, as well as our head offices moving to London in early 2021, you will begin to see some changes to references to our products, contact details, materials and statements over the coming months.
Product Description
|
Supply Status
|
Estimated Resupply Date
|
GARDASIL® (National Immunisation Programme)
|
Full Supply
|
|
GARDASIL®
|
To be discontinued
|
Available until May 2021
|
GARDASIL® 9
|
Full Supply
|
|
VAQTA® Paediatric
|
Full Supply
|
|
VAQTA® Adult
|
Full Supply
|
|
HBVAXPRO®
5mcg
|
Full Supply
|
|
HBVAXPRO®
10mcg
|
Out of Stock
|
April 2021
|
HBVAXPRO®
40mcg
|
Full Supply
|
|
M-M-RVAXPRO® (National Immunisation Programme)
|
Full Supply
|
|
M-M-RVAXPRO®
|
Full Supply
|
|
PNEUMOVAX® 23
(pre-filled syringes)
|
Limited Supply
|
|
VARIVAX®
|
Full Supply
|
|
ZOSTAVAX® (National Immunisation Programme)
|
Full Supply
|
|
ZOSTAVAX®
|
Full Supply
|
This page is intended for use by UK healthcare professionals only. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck & Co., Inc., Kenilworth, NJ, USA, its subsidiaries or affiliates, except as noted.
Job code: GB-NON-04151Date of preparation: April 2021